請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48750
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭育良 | |
dc.contributor.author | Hung-Pin Wu | en |
dc.contributor.author | 吳弘斌 | zh_TW |
dc.date.accessioned | 2021-06-15T07:11:57Z | - |
dc.date.available | 2016-03-03 | |
dc.date.copyright | 2011-03-03 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-09-27 | |
dc.identifier.citation | 1. Daniel E. Noise and hearing loss: a review. J Sch Health 2007;77:225-231.
2. Mandel JH, Luxenberg M. Diabetes and hearing loss. J Occup Med 1988;30:271-272. 3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431. 4. Von Korff M, Katon W, Lin EHet al. Work disability among individuals with diabetes. Diabetes Care 2005;28:1326-1332. 5. Mokdad AH, Ford ES, Bowman BAet al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama 2003;289:76-79. 6. Wackym PA, Linthicum FH, Jr. Diabetes mellitus and hearing loss: clinical and histopathologic relationships. Am J Otol 1986;7:176-182. 7. Kovar M. The inner ear in diabetes mellitus. ORL J Otorhinolaryngol Relat Spec 1973;35:42-51. 8. Smith TL, Raynor E, Prazma J, Buenting JE, Pillsbury HC. Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 1995;105:236-240. 9. Stolk RP, Boomsma LJ. Prevalence of deafness is increased in patients with type 2 diabetes in The Netherlands. Diabetes Care 1999;22:180. 10. Varkonyi TT, Toth F, Rovo Let al. Impairment of the auditory brainstem function in diabetic neuropathy. Diabetes Care 2002;25:631-632. 11. Seidl R, Birnbacher R, Hauser E, Bernert G, Freilinger M, Schober E. Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM. Diabetes Care 1996;19:1220-1224. 12. Rabinowitz PM. Noise-induced hearing loss. Am Fam Physician 2000;61:2749-2756, 2759-2760. 13. Ishii EK, Talbott EO, Findlay RC, D'Antonio JA, Kuller LH. Is NIDDM a risk factor for noise-induced hearing loss in an occupationally noise exposed cohort? Sci Total Environ 1992;127:155-165. 14. Hodgson MJ, Talbott E, Helmkamp JC, Kuller LH. Diabetes, noise exposure, and hearing loss. J Occup Med 1987;29:576-579. 15. Wassick KH, Yonovitz A. Methyl mercury ototoxicity in mice determined by auditory brainstem responses. Acta Otolaryngol 1985;99:35-45. 16. Hsu CJ, Liu TC, Lin KN. Effect of acoustic trauma on cytochrome oxidase activity in stria vascularis. ORL J Otorhinolaryngol Relat Spec 1998;60:314-317. 17. Probst R, Lonsbury-Martin BL, Martin GK. A review of otoacoustic emissions. J Acoust Soc Am 1991;89:2027-2067. 18. Tan CT, Hsu CJ, Lee SY, Liu SH, Lin-Shiau SY. Potentiation of noise-induced hearing loss by amikacin in guinea pigs. Hear Res 2001;161:72-80. 19. Brown AM, Kemp DT. Suppressibility of the 2f1-f2 stimulated acoustic emissions in gerbil and man. Hear Res 1984;13:29-37. 20. Serdaroglu I, Islamoglu K, Ozgentas E. Effects of insulin-dependent diabetes mellitus on perforator-based flaps in streptozotocin diabetic rats. J Reconstr Microsurg 2005;21:51-56. 21. Mazurek B, Winter E, Fuchs J, Haupt H, Gross J. Susceptibility of the hair cells of the newborn rat cochlea to hypoxia and ischemia. Hear Res 2003;182:2-8. 22. Di Nardo W, Ghirlanda G, Paludetti Get al. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM. Diabetes Care 1998;21:1317-1321. 23. Chan E, Suneson A, Ulfendahl M. Acoustic trauma causes reversible stiffness changes in auditory sensory cells. Neuroscience 1998;83:961-968. 24. Lataye R, Campo P. Combined effects of a simultaneous exposure to noise and toluene on hearing function. Neurotoxicol Teratol 1997;19:373-382. 25. Fechter LD, Young JS, Carlisle L. Potentiation of noise induced threshold shifts and hair cell loss by carbon monoxide. Hear Res 1988;34:39-47. 26. Warr WB, Guinan JJ, Jr. Efferent innervation of the organ of corti: two separate systems. Brain Res 1979;173:152-155. 27. Mountain DC. Changes in endolymphatic potential and crossed olivocochlear bundle stimulation alter cochlear mechanics. Science 1980;210:71-72. 28. Collet L, Kemp DT, Veuillet E, Duclaux R, Moulin A, Morgon A. Effect of contralateral auditory stimuli on active cochlear micro-mechanical properties in human subjects. Hear Res 1990;43:251-261. 29. Kujawa SG, Liberman MC. Effects of olivocochlear feedback on distortion product otoacoustic emissions in guinea pig. J Assoc Res Otolaryngol 2001;2:268-278. 30. Lewis RS, Hudspeth AJ. Voltage- and ion-dependent conductances in solitary vertebrate hair cells. Nature 1983;304:538-541. 31. Fridberger A, Flock A, Ulfendahl M, Flock B. Acoustic overstimulation increases outer hair cell Ca2+ concentrations and causes dynamic contractions of the hearing organ. Proc Natl Acad Sci U S A 1998;95:7127-7132. 32. Brookes PS. Mitochondrial nitric oxide synthase. Mitochondrion 2004;3:187-204. 33. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004;287:C817-833. 34. Sasaki H, Schmelzer JD, Zollman PJ, Low PA. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol 1997;93:118-128. 35. Nishikawa T, Edelstein D, Du XLet al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790. 36. Huang TJ, Price SA, Chilton Let al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003;52:2129-2136. 37. Hall AJ, Lutman ME. Methods for early identification of noise-induced hearing loss. Audiology 1999;38:277-280. 38. Attias J, Bresloff I. Noise induced temporary otoacoustic emission shifts. J Basic Clin Physiol Pharmacol 1996;7:221-233. 39. Eddins AC, Zuskov M, Salvi RJ. Changes in distortion product otoacoustic emissions during prolonged noise exposure. Hear Res 1999;127:119-128. 40. Jeitler K, Horvath K, Berghold Aet al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941-951. 41. Bratusch-Marrain PR, Komjati M, Waldhausl WK. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 1986;35:922-926. 42. Grubert JM, Lautz M, Lacy DBet al. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake. Am J Physiol Endocrinol Metab 2005;289:E232-240. 43. Kopke R, Allen KA, Henderson D, Hoffer M, Frenz D, Van de Water T. A radical demise. Toxins and trauma share common pathways in hair cell death. Ann N Y Acad Sci 1999;884:171-191. 44. Yamane H, Nakai Y, Takayama M, Iguchi H, Nakagawa T, Kojima A. Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Eur Arch Otorhinolaryngol 1995;252:504-508. 45. Clerici WJ, Yang L. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 1996;101:14-22. 46. Fechter LD, Liu Y, Pearce TA. Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig. Toxicol Appl Pharmacol 1997;142:47-55. 47. Ohlemiller KK, Wright JS, Dugan LL. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol 1999;4:229-236. 48. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004;25:612-628. 49. Rahman Q, Abidi P, Afaq Fet al. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol 1999;29:543-568. 50. Kopke RD, Jackson RL, Coleman JK, Liu J, Bielefeld EC, Balough BJ. NAC for noise: from the bench top to the clinic. Hear Res 2007;226:114-125. 51. Coleman JK, Kopke RD, Liu Jet al. Pharmacological rescue of noise induced hearing loss using N-acetylcysteine and acetyl-L-carnitine. Hear Res 2007;226:104-113. 52. Lin CD, Oshima T, Oda K, Yamauchi D, Tsai MH, Kobayashi T. Ototoxic interaction of kanamycin and 3-nitropropionic acid. Acta Otolaryngol 2008;128:1280-1285. 53. Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, Russell JW. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. diabetes 2004;53:726-734. 54. Santos MS, Santos DL, Palmeira CM, Seica R, Moreno AJ, Oliveira CR. Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress. Diabetes Metab Res Rev 2001;17:223-230. 55. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. 56. Vincent AM, Edwards JL, Sadidi M, Feldman EL. The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets 2008;9:94-100. 57. Fukushima H, Cureoglu S, Schachern PAet al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg 2005;133:100-106. 58. Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007;27:130-143. 59. Medina-Navarro R, Duran-Reyes G, Diaz-Flores M, Hicks JJ, Kumate J. Glucose-stimulated acrolein production from unsaturated fatty acids. Hum Exp Toxicol 2004;23:101-105. 60. Shin AH, Oh CJ, Park JW. Glycation-induced inactivation of antioxidant enzymes and modulation of cellular redox status in lens cells. Arch Pharm Res 2006;29:577-581. 61. Vincent AM, Perrone L, Sullivan KAet al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007;148:548-558. 62. Kopke RD, Coleman JK, Liu J, Campbell KC, Riffenburgh RH. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss. Laryngoscope 2002;112:1515-1532. 63. Bielefeld EC, Kopke RD, Jackson RL, Coleman JK, Liu J, Henderson D. Noise protection with N-acetyl-l-cysteine (NAC) using a variety of noise exposures, NAC doses, and routes of administration. Acta Otolaryngol 2007;127:914-919. 64. Chen GD, Fechter LD. The relationship between noise-induced hearing loss and hair cell loss in rats. Hear Res 2003;177:81-90. 65. Borg E, Engstrom B. Noise level, inner hair cell damage, audiometric features, and equal-energy hypothesis. J Acoust Soc Am 1989;86:1776-1782. 66. Chen GD, McWilliams ML, Fechter LD. Succinate dehydrogenase (SDH) activity in hair cells: a correlate for permanent threshold elevations. Hear Res 2000;145:91-100. 67. Engstrom B, Borg E. Cochlear morphology in relation to loss of behavioural, electrophysiological, and middle ear reflex thresholds after exposure to noise. Acta Otolaryngol Suppl 1983;402:5-23. 68. Cullen JR, Cinnamond MJ. Hearing loss in diabetics. J Laryngol Otol 1993;107:179-182. 69. Austin DF, Konrad-Martin D, Griest S, McMillan GP, McDermott D, Fausti S. Diabetes-related changes in hearing. Laryngoscope 2009;119:1788-1796. 70. Frisina ST, Mapes F, Kim S, Frisina DR, Frisina RD. Characterization of hearing loss in aged type II diabetics. Hear Res 2006;211:103-113. 71. Huang YM, Pan CY, Gu R, Cai XH, Yu LM, Qiu CY. Hearing impairment in diabetics. Chin Med J (Engl) 1992;105:44-48. 72. Di Leo MA, Di Nardo W, Cercone Set al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997;20:824-828. 73. Elamin A, Fadlallah M, Tuevmo T. Hearing loss in children with type 1 diabetes. Indian Pediatr 2005;42:15-21. 74. Pessin AB, Martins RH, Pimenta Wde P, Simoes AC, Marsiglia A, Amaral AV. Auditory evaluation in patients with type 1 diabetes. Ann Otol Rhinol Laryngol 2008;117:366-370. 75. Hirose K. Hearing loss and diabetes: you might not know what you're missing. Ann Intern Med 2008;149:54-55. 76. Ren J, Zhao P, Chen L, Xu A, Brown SN, Xiao X. Hearing loss in middle-aged subjects with type 2 diabetes mellitus. Arch Med Res 2009;40:18-23. 77. Lisowska G, Namyslowski G, Morawski K, Strojek K. Early identification of hearing impairment in patients with type 1 diabetes mellitus. Otol Neurotol 2001;22:316-320. 78. Durmus C, Yetiser S, Durmus O. Auditory brainstem evoked responses in insulin-dependent (ID) and non-insulin-dependent (NID) diabetic subjects with normal hearing. Int J Audiol 2004;43:29-33. 79. Vaughan N, James K, McDermott D, Griest S, Fausti S. Auditory brainstem response differences in diabetic and non-diabetic veterans. J Am Acad Audiol 2007;18:863-871. 80. Konrad-Martin D, Austin DF, Griest S, McMillan GP, McDermott D, Fausti S. Diabetes-related changes in auditory brainstem responses. Laryngoscope 2010;120:150-158. 81. Guinan JJ, Jr., Warr WB, Norris BE. Differential olivocochlear projections from lateral versus medial zones of the superior olivary complex. J Comp Neurol 1983;221:358-370. 82. Kumar UA, Vanaja CS. Functioning of olivocochlear bundle and speech perception in noise. Ear Hear 2004;25:142-146. 83. Micheyl C, Collet L. Involvement of the olivocochlear bundle in the detection of tones in noise. J Acoust Soc Am 1996;99:1604-1610. 84. Kawase T, Liberman MC. Antimasking effects of the olivocochlear reflex. I. Enhancement of compound action potentials to masked tones. J Neurophysiol 1993;70:2519-2532. 85. Hienz RD, Stiles P, May BJ. Effects of bilateral olivocochlear lesions on vowel formant discrimination in cats. Hear Res 1998;116:10-20. 86. Ugur AK, Kemaloglu YK, Ugur MBet al. Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children. Int J Pediatr Otorhinolaryngol 2009;73:555-559. 87. Namyslowski G, Morawski K, Kossowska I, Lisowska G, Koehler B, Jarosz-Chobot P. Contralateral suppression of TEOAE in diabetic children. Effects of 1.0 kHz and 2.0 kHz pure tone stimulation--preliminary study. Scand Audiol Suppl 2001:126-129. 88. Rajan R. Electrical stimulation of the inferior colliculus at low rates protects the cochlea from auditory desensitization. Brain Res 1990;506:192-204. 89. Cody AR, Johnstone BM. Temporary threshold shift modified by binaural acoustic stimulation. Hear Res 1982;6:199-205. 90. Patuzzi RB, Thompson ML. Cochlear efferent neurones and protection against acoustic trauma: protection of outer hair cell receptor current and interanimal variability. Hear Res 1991;54:45-58. 91. Rajan R. Frequency and loss dependence of the protective effects of the olivocochlear pathways in cats. J Neurophysiol 1995;74:598-615. 92. Zheng XY, McFadden SL, Ding DL, Henderson D. Cochlear de-efferentation and impulse noise-induced acoustic trauma in the chinchilla. Hear Res 2000;144:187-195. 93. Maison SF, Liberman MC. Predicting vulnerability to acoustic injury with a noninvasive assay of olivocochlear reflex strength. J Neurosci 2000;20:4701-4707. 94. Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. diabetes 1998;47:1967-1970. 95. Hildesheimer M, Makai E, Muchnik C, Rubinstein M. The influence of the efferent system on acoustic overstimulation. Hear Res 1990;43:263-267. 96. Kujawa SG, Liberman MC. Long-term sound conditioning enhances cochlear sensitivity. J Neurophysiol 1999;82:863-873. 97. Yoshida N, Liberman MC. Sound conditioning reduces noise-induced permanent threshold shift in mice. Hear Res 2000;148:213-219. 98. Wu HP, Cheng TJ, Tan CT, Guo YL, Hsu CJ. Diabetes impairs recovery from noise-induced temporary hearing loss. Laryngoscope 2009;119:1190-1194. 99. Wu HP, Hsu CJ, Cheng TJ, Guo YL. N-acetylcysteine attenuates noise-induced permanent hearing loss in diabetic rats. Hear Res 2010;267:71-77. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48750 | - |
dc.description.abstract | 糖尿病與噪音性聽力損失均是影響健康與生活品質的重要因素,病理與動物研究顯示兩者之間是有可能互相影響的,然而在流行病學觀察型研究卻有著爭議,本研究打算以動物模式來探討兩者之間的關係:1. 探討糖尿病是否會影響暫時性噪音性聽力損失的恢復;2. 探討糖尿病是否會使永久性噪音性聽力損失更嚴重及聽力保護藥物於糖尿病鼠的功能;3. 探討糖尿病於聽覺傳導路徑的影響。
第一部分,先探討糖尿病是否會影響暫時性噪音性聽力損失的恢復。28隻雄性Wistar鼠,分為三組:控制組 (C), 糖尿病有胰島素治療組(DI), 糖尿病沒有胰島素治療組(DM)。使用Streptozotocin來誘發老鼠產生糖尿病,所有鼠均暴露於110分貝噪音下達八小時,腦幹聽性誘發反應和歪成耳聲傳射檢查、 在噪音暴露前一天的資料作為基準值,並於噪音暴露後一小時、一天、兩天、四天、七天和十四天後再測。發現腦幹聽性誘發反應和歪成耳聲傳射檢查、在C組第一天就恢復,DM組第十四天才恢復,而DI組則介於兩者之間,本實驗建議糖尿病人需要合適的血糖控制及更周全的保護來對抗噪音。 第二部分,探討經由反覆的噪音暴露,糖尿病是否會使永久性噪音性聽力損失更嚴重及N-acetylcysteine (NAC)一種抗氧化劑的前驅物,是否會使糖尿病鼠的噪音性聽力損失減少。50隻雄性Wistar鼠,分為四組:12隻打生理食鹽水的控制組 (Control-Saline), 11 隻打NAC的控制組(Control-NAC), 13隻打生理食鹽水的糖尿病組(Diabetes-Saline) and 14隻打NAC的糖尿病組(Diabetes-NAC)。NAC (325 mg/kg) 每天兩次腹腔注射,從噪音暴露前兩天開始,連續十四天,所有鼠均暴露於110分貝噪音下達八小時,連續十天以產生永久性噪音性聽力損失。腦幹聽性誘發反應分別在噪音暴露前,與後一小時、一週、兩週與四週後量測,之後將鼠的耳蝸取下,於光學顯微鏡下計算耳蝸毛細胞的數目。結果於四週後,Diabetes-Saline的聽力損失最嚴重達36.9 ± 2.3 分貝,Control-Saline 和 Diabetes-NAC 次之, Control-NAC最少為19.5 ± 2.0分貝,此外耳蝸圖發現僅有Diabetes-Saline的外毛細胞有相當程度的損失。 第三部分,探討(1) compromised medial olivocochlear bundle (MOCB) activities and腦幹聽性誘發反應(ABR)的時間進程和(2) 胰島素於糖尿病相關聽覺障礙的影響。30隻雄性Wistar鼠,分為三組:控制組 (C), 糖尿病有胰島素治療組(DI), 糖尿病沒有胰島素治療組(DM)。每月測量ABR、歪成耳聲傳射檢查、歪成耳聲傳射檢查的對側抑制。在研究期間,各組的聽力均無明顯上升,但DM組在第二十九週時的腦幹聽性誘發反應wave III與I-III有延長(p<0.05)、在第二十五週時歪成耳聲傳射檢查的對側抑制有明顯下降的現象,但C與DI組均無此現象,也就是說糖尿病鼠在ABR尚未出現明顯變化前, 歪成耳聲傳射檢查的對側抑制有明顯下降的現象, Compromised medial olivocochlear bundle (MOCB) activities的時間進程與糖尿病的時間有正相關且胰島素有保護的作用。 總結起來:(1)糖尿病會減慢暫時性噪音性聽力損失的恢復;(2) 糖尿病會使永久性噪音性聽力損失更嚴重,此外NAC會保護內耳外毛細胞並同時減緩糖尿病鼠與非糖尿病鼠的噪音性聽力損失;(3) 歪成耳聲傳射檢查的對側抑制比腦幹聽性誘發反應更適合做為糖尿病相關聽力損失的早期指標。 | zh_TW |
dc.description.abstract | Diabetes and noise induced hearing loss (NIHL) are both very common conditions affecting the health and quality of life. The pathologic and animal studies suggest plausible biologic interactions between diabetes and noise. However, in epidemiologic observational studies revealed controversial results. The purpose of this study is to investigate 1. whether diabetes impairs the recovery from noised-induced temporary hearing loss; 2. whether diabetes exaggerates permanent threshold shifts and the role of otoprotective agents in diabetic rats.; 3. the possible mechanism interacts between diabetes and auditory pathway.
In the first part of the study, we try to investigate whether diabetes impairs the recovery from noised-induced temporary hearing loss. Twenty-eight male Wistar rats were divided into three groups: control (C), diabetes with insulin control (DI), and diabetes without insulin control (DM). Diabetes was induced by intraperitoneal injection of streptozotocin. All animals were exposed to white noise at 110dB SPL for eight hours. Auditory brainstem response (ABR) thresholds and distortion product otoacoustic emission (DPOAE) amplitudes were measured for all animals one day prior to noise exposure, to obtain a baseline for hearing function, and then one hour, one day, two days, four days, seven days, and 14 days after noise exposure. One hour post exposure, ABR thresholds shifted markedly, and DPOAE was reduced similarly in all groups. Both ABR thresholds and DPOAE returned to the baseline in the control group at day 1, but they were not back to the baseline in the DM group even by day 14. Compared with the control group, the ABR threshold shifts and DPOAE returned to baseline more slowly in the DI group. The present study suggests that diabetic patients need proper blood sugar control and probably need more effective preventive measures to preserve their hearing from the effects of noise. In the second part of the study, we try to investigate whether repeated noise exposure aggravates the level of permanent noise-induced hearing loss (NIHL) in diabetic rats and whether N-acetylcysteine (NAC), a precursor of glutathione, attenuates the level of noise-induced permanent hearing loss in diabetic rats. Fifty male Wistar rats were divided into four groups: 12 non-diabetic control rats with saline injection (Control-Saline), 11 non-diabetic control rats with NAC injection (Control-NAC), 13 streptozotocin-induced diabetic rats with saline injection (Diabetes-Saline) and 14 streptozotocin-induced diabetic rats with NAC injection (Diabetes-NAC). NAC (325 mg/kg) was given by intraperitoneal injection twice per day (b.i.d.) for 14 days starting 2 days before noise exposure. All rats were exposed to noise for 8 hours per day for 10 consecutive days to develop noise-induced permanent hearing loss. The hearing status of all animals was evaluated with auditory brainstem responses (ABR) evoked by clicks and tone bursts. ABRs were measured before and at 1 hour, 1 week, 2 weeks and 4 weeks after noise exposure. After a recovery time of 4 weeks, animals were decapitated, and the loss of hair cells was assessed microscopically. In all groups, ABR thresholds failed to return to pre-exposure values throughout the experimental period. The ABR threshold to clicks was markedly elevated in the Diabetes-Saline group (36.9 ± 2.3 dB SPL), less elevated in the Control-Saline and Diabetes-NAC groups and least in the Control-NAC group (19.5 ± 2.0 dB SPL) at 4 weeks after noise exposure. Diabetes caused increased susceptibility to noise-induced hearing loss, and NAC treatment reduced the loss in both control and diabetic rats. Cochleograms revealed no gross destruction of hair cells in the non-diabetic groups or the Diabetes-NAC group; however, a significant number of outer hair cells (OHCs) were lost in the Diabetes-Saline group. In the third part of the study, we try to investigate in diabetic rats: (1) the evolution of compromised medial olivocochlear bundle (MOCB) activities and auditory brainstem responses (ABR), and (2) the insulin effect on diabetes-related hearing dysfunction. Thirty male Wistar rats were divided into three groups: control (C), diabetes with insulin injection (DI), and diabetes without insulin injection (DM). Click-evoked ABR, distortion product otoacoustic emission (DPOAE) and the contralateral suppression of DPOAE were measured for all animals monthly. Chronological changes of thresholds of click-evoked ABR in each group were presented without statistical significance among the groups. Wave III was delayed and interpeak latency I-III was prolonged in the DM group at the age of 29 weeks (p<0.05). The amplitudes of the contralateral suppression of DPOAE were markedly decreased after the 25th week in the DM group, but not in the C and DI groups. Compared to the C group, contralateral suppression in the DI group was not compromised through all frequencies. Dysfunction of the auditory efferent olivocochlear activities developed in diabetic subjects presenting no evidence of hearing loss. The clinical finding of a significant decrease of contralateral suppression of DPOAE could be used as an earlier indicator of diabetes-related hearing impairment than the changes of ABRs. The evolution of compromised MOCB is positively related with the duration of diabetes, and insulin could play the protective effect on it. In summary, we conclude that in Wistar rats (1) diabetes may delay the recovery from noise induced temporary hearing loss; (2) diabetics are prone to developing more severe permanent NIHL than non-diabetics and NAC could preserve most OHCs and attenuate the permanent noise-induced hearing loss in both groups;(3) contralateral suppression of DPOAE could be used as an earlier indicator of diabetes-related hearing impairment than the changes of ABRs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T07:11:57Z (GMT). No. of bitstreams: 1 ntu-99-D96841004-1.pdf: 6350460 bytes, checksum: 1d7a34ce98428778ab3061331c222b5f (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 1. Background: ......................................1
1.1 Hearing measurement tools used in the study: .......................................2 1.1.1 Auditory brainstem response (ABR) ....................................2 1.1.2 Distortion product otoacoustic emissions (DPOAE) .....................................3 1.2 Research projects ........................................4 1.3 Study framework ........................................5 1.4 Animals and induction of diabetes ........................................5 1.5 Noise exposure ....................................6 1.6 Sample size determination .......................................6 2. Diabetes impairs the recovery from noise induced temporary hearing loss .......................7 2.1 Objective ..........................................7 2.2 Materials and methods ........................................7 2.2.1 Experimental procedures ........................................7 2.2.2 Statistical analysis ........................................8 2.3 Results ..........................................8 2.4 Discussions .......................................10 2.5 Conclusions .........................................14 2.6 Figures and legends .........................................15 3. N-acetylcysteine attenuates noise induced permanent hearing loss in diabetic rats ...............19 3.1 Introduction ...........................................19 3.2 Material and methods ...........................................20 3.2.1 Noise exposure ........................................20 3.2.2 Hearing measurements .......................................20 3.2.3 Experimental procedures ........................................20 3.2.4 Histological examination ........................................22 3.2.5 Statistical analysis ........................................22 3.3 Results ...........................................23 3.3.1 Body weight and blood glucose changes ........................................23 3.3.2 Chronologic changes in click-evoked ABR ........................................24 3.3.3 Tone burst ABR threshold shifts ........................................25 3.3.4 Histological examination of hair cells ........................................25 3.3.5 Cochleograms ..... ...................................25 3.4 Discussions .........................................26 3.4.1 Combined effect of noise exposure and diabetes on hearing .............................26 3.4.2 Effect of NAC on hearing preservation in diabetic rats..............................27 3.4.3 Relationship between cochleograms and ABR changes ...............................28 3.5 Conclusions ......................................28 3.6 Figures and legends .........................................29 4. Chronological Changes in Compromised Olivocochlear Activity and the Effect of Insulin in Diabetic Wistar Rats .......................................34 4.1 Introduction .........................................34 4.2 Materials and methods .........................................36 4.2.1 Contralateral suppression of DPOAEs .......................................36 4.2.2 Experimental procedures .......................................37 4.2.3 Statistical analysis .......................................38 4.3 Results ........................................38 4.3.1 Body weight and blood glucose changes .......................................38 4.3.2 Chronological ABR changes ..............................................39 4.3.3 Chronological DPOAE changes ...............................................39 4.3.4 Chronological CS of DPOAE changes .........................................39 4.4 Discussions .........................................40 4.5 Conclusions ........................................44 4.6 Figures and legends ..........................................45 5. Summary .......................................52 6. References .......................................54 | |
dc.language.iso | en | |
dc.title | 以動物模式探討糖尿病影響噪音性聽力損失 | zh_TW |
dc.title | Using animal model to investigate diabetic impact on noise induced hearing loss | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-1 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 鄭尊仁,許權振 | |
dc.contributor.oralexamcommittee | 劉紹興,黃耀輝,陳培榕 | |
dc.subject.keyword | 糖尿病,噪音性聽力損失,腦幹聽性誘發反應,歪成耳聲傳射檢查,對側抑制, | zh_TW |
dc.subject.keyword | diabetes,noise induced hearing loss,auditory brainstem response,distortion product otoacoustic emissions,contralateral suppression, | en |
dc.relation.page | 65 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-09-27 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 職業醫學與工業衛生研究所 | zh_TW |
顯示於系所單位: | 職業醫學與工業衛生研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 6.2 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。